Antares Pharma, Inc. ATRS
5.59 +5.59
Day range unavailable
52-week range unavailable
News
zacks.com Antares Pharma (ATRS) Moves 49.2% Higher: Will This Strength Last? Antares Pharma (ATRS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…
invezz.com Antares Pharma Inc shares up 45% on Wednesday: how come? Antares Pharma Inc shares (NASDAQ: ATRS) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement…
benzinga.com Why Antares Pharma Stock Is Soaring Today Antares Pharma Inc (NASDAQ: ATRS) shares are trading higher Wednesday after the company announced it will be acquired by Halozyme Therapeutics Inc (NASDAQ: HALO) for $5.60 per share in cash, valuing…
investorplace.com Why Is Antares Pharma (ATRS) Stock Up Today? Antares Pharma (ATRS) stock is rocketing higher on Wednesday after the company reached an acquisition agreement with Halozyme (HALO). The post Why Is Antares Pharma (ATRS) Stock Up Today?
pennystocks.com Best Penny Stocks to Buy? 3 to Watch as ATRS Stock Explodes Here's what you need to know about trading penny stocks on April 13th The post Best Penny Stocks to Buy? 3 to Watch as ATRS Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and…
fool.com Why Antares Pharma Stock Is Bolting Higher Today The drug delivery specialist has reportedly agreed to a merger with Halozyme.
marketwatch.com Antares Pharma stock rockets after Halozyme buyout deal for a near-50% premium Shares of Antares Pharma Inc. ATRS, -0.27% rocketed 46.3% in premarket trading Wednesday toward a two-decade high, after the specialty pharmaceutical company agreed to be acquired by Halozyme…
benzinga.com Antares Pharma's Oral Testosterone Treatment Scores FDA Approval Antares Pharma Inc (NASDAQ: ATRS) has nabbed another FDA approval, and the Company's second involving testosterone. The Company announced FDA approval for Tlando (testosterone undecanoate), an oral…
seekingalpha.com Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q4 2021 Results - Earnings Call Transcript Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q4 2021 Results - Earnings Call Transcript
zacks.com Antares Pharma (ATRS) Surpasses Q4 Earnings and Revenue Estimates Antares Pharma (ATRS) delivered earnings and revenue surprises of 100% and 5.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
benzinga.com Earnings Scheduled For March 3, 2022 Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
globenewswire.com Antares Pharma to Present at the Cowen 42nd Annual Healthcare Conference EWING, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief…
globenewswire.com Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results EWING, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced it will release its fourth quarter and…
seekingalpha.com A Look At Recent Moves By Antares Pharma Antares is a company I've followed for years, and I recently decided to reinitiate a position. That's because the stock price has fallen significantly with the broader market while management has…
benzinga.com FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity The FDA has granted Fast Track designation to Antares Pharma Inc's (NASDAQ: ATRS) for ATRS-1902 for adrenal crisis rescue. The development program for ATRS-1902 supports a proposed indication of…
seekingalpha.com Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q3 2021 Results - Earnings Call Transcript Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q3 2021 Results - Earnings Call Transcript
benzinga.com Earnings Scheduled For November 4, 2021 Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
zacks.com Antares Pharma (ATRS) Reports Next Week: What to Expect Antares Pharma (ATRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
globenewswire.com Antares Pharma to Report Third Quarter 2021 Financial and Operating Results EWING, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced it will release its third quarter 2021…
globenewswire.com Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue Pharmacokinetic data results expected in 1Q 2022 Pharmacokinetic data results expected in 1Q 2022
globenewswire.com Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference EWING, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief…
fool.com Got $1,000? These 2 Bargain-Bin Biopharma Stocks Might Be Worth Buying These healthcare stocks have their warts, but the price is right for long-term investors.
benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.- benzinga.com Earnings Scheduled For May 6, 2021 Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 558 companies set new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Friday During the morning session on Friday, 389 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Monday During the morning session on Monday, 372 stocks hit new 52-week highs.
- benzinga.com Earnings Scheduled For November 5, 2020 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
benzinga.com Stocks That Hit 52-Week Lows On Monday - benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
benzinga.com Stocks That Hit 52-Week Lows On Monday - benzinga.com Stocks That Hit 52-Week Highs On Monday
- benzinga.com Stocks That Hit 52-Week Highs On Friday
benzinga.com Stocks That Hit 52-Week Highs On Wednesday - benzinga.com Stocks That Hit 52-Week Highs On Tuesday
- benzinga.com 26 Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 52 Biggest Movers From Yesterday
- benzinga.com 44 Stocks Moving In Monday's Mid-Day Session
- benzinga.com 10 Stocks With Three-Day Increasing Volume
benzinga.com Earnings Scheduled For March 13, 2014 - benzinga.com Earnings Scheduled For March 13, 2013